How NMN, NR and NAD+ relate
| NAD+ | NMN | NR | |
|---|---|---|---|
| What it is | The working coenzyme, used by more than 400 enzymes | Nicotinamide mononucleotide, a niacin-like precursor | Nicotinamide riboside, a niacin-like precursor |
| Human trials | Not the focus of the human trials reviewed | Small trials, about 14 to 108 people, 2 to 24 weeks | Mostly 40 people or fewer, 1 to 20 weeks |
How oral NR and NMN are handled in the body is complex and not fully understood. Researchers still debate whether NMN must be broken down to NR to enter cells, and gut bacteria may convert some NR to nicotinic acid. So the idea that NMN is better because it is "one step closer" to NAD+ is not proven.
What the evidence shows
- Both raise NAD+ markers in blood or some tissues in most studies, but not all.
- NR: several randomized trials found no effect on common clinical outcomes such as insulin sensitivity, energy use or exercise capacity. A few small studies saw modest changes in blood pressure or inflammation markers.
- NMN: a few trials reported better muscle insulin sensitivity or exercise performance. Many found no effect on heart, metabolic, cognitive or sleep outcomes, and one review summed up 12 weeks of NMN in healthy adults as having limited effectiveness.
- Head-to-head: we found no good trials comparing NMN with NR directly on health outcomes.
Evidence strength: early. See NAD+ supplements for the wider picture, including niacin.
Is NMN legal as a supplement?
Since September 2025, FDA's stated view is that NMN is not excluded from the dietary supplement definition. In November 2022 FDA said NMN could not be sold as a supplement because it had first been authorized for study as a new drug. A citizen petition asked FDA to change that view, and FDA posted its response letter on the petition docket on September 29, 2025.
Legal summaries of FDA's September 2025 letters, such as Venable's, report that FDA found NMN had been marketed as a supplement before the drug study was authorized, so it is not excluded from the supplement definition. They also report that NMN is still a new dietary ingredient, so each maker generally must notify FDA before selling it, and that FDA's view could be reconsidered later.
This is about legal status, not safety or benefit. FDA does not approve any dietary supplement before it is sold. Some older pages still describe the 2022 position.
Safety and buying tips
- NMN appeared safe for up to 24 weeks in trials, and NR has been well tolerated in short trials. Long-term safety isn't known for either.
- In one trial, high-dose NR with pterostilbene raised LDL cholesterol.
- Pregnancy, breastfeeding, liver or kidney disease, or cancer treatment: ask your clinician first.
- Look for a product tested by an independent lab, since amounts and purity vary by brand.
Gabriel can explain a supplement label or check it against your medicines for free.
Common questions
Is NMN better than NAD+?
Not proven. NMN is a precursor your body turns into NAD+, and human trials have mostly tested precursors rather than NAD+ itself. Neither has clear health benefits in human trials yet.
Is NMN better than NR?
There's no good head-to-head evidence. NR has more human trials; both raise NAD+ markers and both show mixed results on health outcomes.
Did the FDA ban NMN?
In 2022 FDA said NMN couldn't be sold as a supplement. After a citizen petition, FDA reversed that view in September 2025 letters, as summarized by legal analysts. Being allowed as a supplement is not an FDA approval.
Does NMN have side effects?
Trials up to 24 weeks found it safe and well tolerated. Long-term effects are unknown, so ask your clinician if you have a chronic condition or take medicines.
Can you take NAD+ directly?
Human research has focused on the precursors NR and NMN, not NAD+ itself, and the trials reviewed here did not study NAD+ by IV.
Sources
- Dietary Supplementation With NAD+-Boosting Compounds in Humans: Current Knowledge and Future Directions (Freeberg et al., 2023) The Journals of Gerontology: Series A
- Niacin: Fact Sheet for Health Professionals NIH Office of Dietary Supplements
- Response letter, citizen petition docket FDA-2023-P-1867 (posted September 29, 2025) U.S. Food and Drug Administration, via Regulations.gov
- FDA Declares Nicotinamide Mononucleotide Is a Dietary Supplement (legal summary) Venable LLP
- Questions and Answers on Dietary Supplements U.S. Food and Drug Administration
This guide is general information, not medical advice. It does not replace a visit with a licensed clinician. Gabriel membership is not health insurance.